Frohlich Tom
CIK 0001823925
Chief Operating OfficerDirector
Filings
7
Latest Feb 13, 2026
Issuers covered
2
Showing
7 of 7
Page 1
Track record
1 of 4 open-market trades scored (25% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -4.8% | -4.8% | -4.8% | -4.8% |
| 90 days | 1 | 0% | -7.8% | -7.8% | -7.8% | -7.8% |
| 180 days | 1 | 100% | +36.1% | +36.1% | +36.1% | +36.1% |
| 365 days | 1 | 100% | +199.7% | +199.7% | +199.7% | +199.7% |
Issuers
Companies where Frohlich Tom has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KDNY | Chinook Therapeutics, Inc. | 5 | Aug 11, 2023 |
| AVTE | Aerovate Therapeutics, Inc. | 2 | Feb 13, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|